Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion type Assertion NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_head.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion evidence source_evidence_literature NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion SIO_000772 23010638 NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion wasDerivedFrom befree-20140225 NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion wasGeneratedBy ECO_0000203 NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.